The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...

This new drug is a non-opioid analgesic, the first of its kind, designed to treat moderate to severe acute pain in adults. Journavx works by targeting a pain-signaling pathway involving sodium ...

Acute pain is short-term pain often caused by surgery ... According to the FDA, Journavx “reduces pain by targeting a pain-signaling pathway involving sodium channels in the peripheral nervous ...

There is good news for those with acute pain, as the FDA has approved a first-of-its-kind pain medication, and it’s one ...